Condition: Mammaplasty · Breast Cancer · Poland Syndrome · Sponsor: Establishment Labs
The present study will be based on a hybrid breast reconstruction approach with initial skin expansion using the Motiva Flora® Tissue Expander followed by a serial fat grafting session and a final step that includes the placement of a permanent breast implant Ergonomix2®.
This description comes directly from the study's public registry record.
Lilián Patricia Palma López · +34649713486 · lpalma@establishmentlabs.com
Laura García Jimenez · lgarcia@establishmentlabs.com
Always discuss trial participation with your own doctor first.
| Universitair Ziekenhuis Gent | Ghent, Belgium | Recruiting |
| Hospital Universitario San Ignacio | Bogotá, Colombia | Not Yet Recruiting |
| Hospital UNIBE | San José, Costa Rica | Not Yet Recruiting |
| Hospital de la Santa Creu i Sant Pau | Barcelona, Spain | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06146231